Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alexandra Y. Tsidulko"'
Autor:
Alexandra Y. Tsidulko, Oleg B. Shevelev, Anna S. Khotskina, Mariia A. Kolpakova, Anastasia V. Suhovskih, Galina M. Kazanskaya, Alexander M. Volkov, Svetlana V. Aidagulova, Evgenii L. Zavyalov, Elvira V. Grigorieva
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Adjuvant chemotherapy with temozolomide (TMZ) is an intrinsic part of glioblastoma multiforme (GBM) therapy targeted to eliminate residual GBM cells. Despite the intensive treatment, a GBM relapse develops in the majority of cases resulting in poor o
Externí odkaz:
https://doaj.org/article/51ec4338a983464d874d2e3e6aa66255
Autor:
Alexandra Y. Tsidulko, Cynthia Bezier, Gabin de La Bourdonnaye, Anastasia V. Suhovskih, Tatiana M. Pankova, Galina M. Kazanskaya, Svetlana V. Aidagulova, Elvira V. Grigorieva
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Temozolomide (TMZ) is a conventional chemotherapy drug for adjuvant treatment of glioblastoma multiforme (GBM), often accompanied by dexamethasone (DXM) to prevent brain oedema and alleviate clinical side effects. Here, we aimed to investigate an abi
Externí odkaz:
https://doaj.org/article/255a8eb34d7740c882894190f5e5dbbe
Autor:
Grigorieva, Dmitry K. Sokolov, Oleg B. Shevelev, Anna S. Khotskina, Alexandra Y. Tsidulko, Anastasia V. Strokotova, Galina M. Kazanskaya, Alexander M. Volkov, Evgenii E. Kliver, Svetlana V. Aidagulova, Evgenii L. Zavjalov, Elvira V.
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10243
Glioblastoma (GB) is an aggressive cancer with a high probability of recurrence, despite active chemoradiotherapy with temozolomide (TMZ) and dexamethasone (DXM). These systemic drugs affect the glycosylated components of brain tissue involved in GB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::45d9f022feb296fd970e1045fda0390b
Autor:
Alexandra Y. Tsidulko, Elvira V. Grigorieva, Galina M. Kazanskaya, Alexander M. Volkov, Anastasia V. Suhovskih, Svetlana V. Aidagulova
Publikováno v:
Histochemistry and Cell Biology. 152:239-247
Histological and immunohistochemical studies require high-quality paraffin blocks, where proper fixation of tissue samples with formalin is a key point. However, in some cases, the possibility to preserve biological samples prior to the formalin fixa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c29abf5700d4cd2c38780e9af15f72
https://doi.org/10.1007/s00418-019-01799-z
https://doi.org/10.1007/s00418-019-01799-z
Autor:
Oxana A. Pashkovskaya, Elvira V. Grigorieva, Alexandra Y. Tsidulko, Konstantin E. Kuper, Svetlana V. Aidagulova, Alexander A. Zheravin, Anna I. Prokaeva, Maxim O. Politko, Evgenii E. Kliver
Publikováno v:
Molecular biology reports. 47(7)
Radiotherapy is an integral part of glioblastoma treatment affecting both cancer cells and tumour microenvironment, where proteoglycans (PGs) are key extracellular components. However, the molecular effects of radiotherapy on PGs expression and funct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbec729e6027def47b59ad079df8e92
https://pubmed.ncbi.nlm.nih.gov/32514998
https://pubmed.ncbi.nlm.nih.gov/32514998
Autor:
Galina M. Kazanskaya, Anastasia V. Suhovskih, Alexandra Y. Tsidulko, Elvira V. Grigorieva, Svetlana V. Aidagulova, Alexander M. Volkov
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 4
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1301 (2020)
Volume 21
Issue 4
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1301 (2020)
Adjuvant chemoradiotherapy is a standard treatment option for glioblastoma multiforme (GBM). Despite intensive care, recurrent tumors developed during the first year are fatal for the patients. Possibly contributing to this effect, among other causes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20908ae0b973e56e76f17d4bbad84a57
Autor:
I. O. Petruseva, Olga I. Lavrik, Vladimir N. Silnikov, Lyudmila S. Koroleva, A. N. Evdokimov, Alexandra Y. Tsidulko, Alexander V. Popov, Yury N. Vorobiev, Alexander A. Lomzov
Publikováno v:
DNA Repair. 61:86-98
Mammalian nucleotide excision repair (NER) eliminates the broadest diversity of bulky lesions from DNA with wide specificity. However, the double incision efficiency for structurally different adducts can vary over several orders of magnitude. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a71f80baba26aad8e91bc0b009c6df
https://doi.org/10.1016/j.dnarep.2017.10.010
https://doi.org/10.1016/j.dnarep.2017.10.010
Autor:
Maxim O. Politko, Konstantin E. Kuper, Elvira V. Grigorieva, Svetlana V. Aidagulova, Galina M. Kazanskaya, Anastasia V. Suhovskih, Alexandra Y. Tsidulko, O. Pashkovskaya, Alexander M. Volkov, O. Shevelev, M. Kolpakova, E. Zavjalov
Publikováno v:
Annals of Oncology. 31:S246-S247
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::083653a36b5138c2d98fbf8e78f7a6f7
https://doi.org/10.1016/j.annonc.2020.08.159
https://doi.org/10.1016/j.annonc.2020.08.159
Autor:
Svetlana V. Aidagulova, Vyacheslav V. Kobozev, Galina M. Kazanskaya, Roman S. Kiselev, Alexandra Y. Tsidulko, Elvira V. Grigorieva, Alexei S. Gaytan, Anastasia V. Suhovskih, Alexei L. Krivoshapkin, Alexander M. Volkov
Publikováno v:
Histochemistry and cell biology. 149(3)
Glycosaminoglycans are major components of brain extracellular matrix (ECM), although heparan sulfate (HS) contribution in brain physiology and carcinogenesis remains underinvestigated. This study examined HS content and distribution in glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc54b4793c307f279fc9cb8591bfc2a0
https://pubmed.ncbi.nlm.nih.gov/29322326
https://pubmed.ncbi.nlm.nih.gov/29322326
Autor:
Ingemar Ernberg, Liudmila Matskova, Alexandra Y. Tsidulko, Lidiia Astakhova, Elvira V. Grigorieva
Publikováno v:
Oncotarget
The involvement of proteoglycans (PGs) in EBV-host interactions and lymphomagenesis remains poorly investigated. In this study, expression of major proteoglycans (syndecan-1, glypican-1, perlecan, versican, brevican, aggrecan, NG2, serglycin, decorin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4d3667f361cbf212f741ac37c1660b
https://doi.org/10.18632/oncotarget.5984
https://doi.org/10.18632/oncotarget.5984